High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic
Papaemmanuil E., Gerstung M., Malcovati L., Tauro S., Gundem G., Van Loo P., Pellagatti A., Groves MJ., Cross NCP., Gambacorti-Passerini C., Green AR., Boultwood J., Vyas P., Hellstrom-Lindberg E., Bowen D., Cazzola M., Stratton MR., Campbell P.